Frontiers in Aging Neuroscience | Parkinson’s Disease and Aging-related Movement Disorders

Perspective

Published on 27 Oct 2022

Management of advanced Parkinson’s disease in Israel: Clinicians viewpoint and action items

in Parkinson’s Disease and Aging-related Movement Disorders

Tanya Gurevich
David Arkadir
Samih Badarny
Sandra Benizri
Oren Cohen
Ruth Djaldetti
Sharon Hassin-Baer
Meir Kestenbaum
Zeev Nitsan
Yair Zlotnik

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.1029824

3,110 views
1 citation

Original Research

Published on 26 Oct 2022

Large-scale frontoparietal theta, alpha, and beta phase synchronization: A set of EEG differential characteristics for freezing of gait in Parkinson’s disease?

in Parkinson’s Disease and Aging-related Movement Disorders

Fatemeh Karimi
Quincy Almeida
Ning Jiang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.988037

6,032 views
2 citations

Review

Published on 20 Oct 2022

State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell us

in Parkinson’s Disease and Aging-related Movement Disorders

Santiago R. Unda
Sabina Marciano
Teresa A. Milner
Roberta Marongiu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.971007

4,881 views
8 citations

Review

Published on 19 Oct 2022

Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Jyotsna Asthana
Bhupendra V. Shravage

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.986849

5,731 views
4 citations

Original Research

Published on 17 Oct 2022

The effect of regional white matter hyperintensities on essential tremor subtypes and severity

in Parkinson’s Disease and Aging-related Movement Disorders

Runcheng He
Yan Qin
Xun Zhou
Zhenhua Liu
Qian Xu
Jifeng Guo
Xinxiang Yan
Beisha Tang
Sheng Zeng
Qiying Sun

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.933093

2,657 views
2 citations

Original Research

Published on 14 Oct 2022

The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity

in Parkinson’s Disease and Aging-related Movement Disorders

Anna Lauritano
Irene Cipollone
Roberta Verde
Hilal Kalkan
Claudia Moriello
Fabio Arturo Iannotti
Vincenzo Di Marzo
Fabiana Piscitelli

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.926634

3,107 views
8 citations

Perspective

Published on 12 Oct 2022

Targeting the inflammasome in Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Qi Su
Wei Lun Ng
Suh Yee Goh
Muhammad Yaaseen Gulam
Lin-Fa Wang
Eng-King Tan
Matae Ahn
Yin-Xia Chao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.957705

6,723 views
15 citations

Original Research

Published on 11 Oct 2022

Alpha-Synuclein species in oral mucosa as potential biomarkers for multiple system atrophy

in Parkinson’s Disease and Aging-related Movement Disorders

Yuanchu Zheng
Huihui Cai
Jiajia Zhao
Zhenwei Yu
Tao Feng

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.1010064

3,031 views
4 citations

Original Research

Published on 06 Oct 2022

Effect of acupuncture for non-motor symptoms in patients with Parkinson’s disease: A systematic review and meta-analysis

in Parkinson’s Disease and Aging-related Movement Disorders

Qinglian Li
Chunxiao Wu
Xiaoling Wang
Zhen Li
Xiaoqian Hao
Lijun Zhao
Mengzhu Li
Meiling Zhu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.995850

5,827 views
23 citations

Original Research

Published on 04 Oct 2022

Mild cognitive impairment is associated with poor gait performance in patients with Parkinson’s disease

in Parkinson’s Disease and Aging-related Movement Disorders

Sung Hoon Kang
Jinhee Kim
Jungyeun Lee
Seong-Beom Koh

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.1003595

2,059 views
5 citations

Systematic Review

Published on 29 Sep 2022

Nilotinib in Parkinson's disease: A systematic review and meta-analysis

in Parkinson’s Disease and Aging-related Movement Disorders

Xiaolu Xie
Ping Yuan
Liqiu Kou
Xiu Chen
Jun Li
Yaling Li

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.996217

5,868 views
10 citations

Original Research

Published on 29 Sep 2022

TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms

in Parkinson’s Disease and Aging-related Movement Disorders

Cinzia Tiloca
Stefano Goldwurm
Narghes Calcagno
Federico Verde
Silvia Peverelli
Daniela Calini
Anna Lena Zecchinelli
Davide Sangalli
Antonia Ratti
Gianni Pezzoli

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.1020948

2,955 views
7 citations

Original Research

Published on 20 Sep 2022

Extended effects of a wearable sensory prosthesis on gait, balance function and falls after 26 weeks of use in persons with peripheral neuropathy and high fall risk—The walk2Wellness trial

in Parkinson’s Disease and Aging-related Movement Disorders

Lars I. E. Oddsson
Teresa Bisson
Helen S. Cohen
Ikechukwu Iloputaife
Laura Jacobs
Doris Kung
Lewis A. Lipsitz
Brad Manor
Patricia McCracken
Yvonne Rumsey

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.931048

5,175 views
7 citations

Original Research

Published on 15 Sep 2022

Amyotrophic lateral sclerosis in seven provinces of Chinese mainland: A cross-sectional survey from 2015 to 2016

in Parkinson’s Disease and Aging-related Movement Disorders

Jie Zhang
Xiaoqing Liu
Huiting Liang
Shengyuan Xu
Xiaohua Wang
Renshi Xu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.946353

5,723 views
6 citations

Original Research

Published on 15 Sep 2022

The long-term trend of Parkinson’s disease incidence and mortality in China and a Bayesian projection from 2020 to 2030

in Parkinson’s Disease and Aging-related Movement Disorders

Fangyao Chen
Shiyu Chen
Aima Si
Yaqi Luo
Weiwei Hu
Yuxiang Zhang
Jiaojiao Ma

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.973310

7,043 views
20 citations

Correction

Published on 14 Sep 2022

Corrigendum: Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson's disease

in Parkinson’s Disease and Aging-related Movement Disorders

Xiu-Lin Liu
Shu-Ying Liu
Olivier Barret
Gilles D. Tamagnan
Hong-Wen Qiao
Tian-Bin Song
Jie Lu
Piu Chan

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2022.1029024

1,459 views

Navigation group

Articles

Management of advanced Parkinson’s disease in Israel: Clinicians viewpoint and action items

Large-scale frontoparietal theta, alpha, and beta phase synchronization: A set of EEG differential characteristics for freezing of gait in Parkinson’s disease?

State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson’s disease: What meta-analysis studies cannot tell us

Exploring therapeutic potential of mitophagy modulators using Drosophila models of Parkinson’s disease

The effect of regional white matter hyperintensities on essential tremor subtypes and severity

The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity

Targeting the inflammasome in Parkinson’s disease

Alpha-Synuclein species in oral mucosa as potential biomarkers for multiple system atrophy

Effect of acupuncture for non-motor symptoms in patients with Parkinson’s disease: A systematic review and meta-analysis

Mild cognitive impairment is associated with poor gait performance in patients with Parkinson’s disease

Nilotinib in Parkinson's disease: A systematic review and meta-analysis

TARDBP mutations in a cohort of Italian patients with Parkinson’s disease and atypical parkinsonisms

Extended effects of a wearable sensory prosthesis on gait, balance function and falls after 26 weeks of use in persons with peripheral neuropathy and high fall risk—The walk2Wellness trial

Amyotrophic lateral sclerosis in seven provinces of Chinese mainland: A cross-sectional survey from 2015 to 2016

The long-term trend of Parkinson’s disease incidence and mortality in China and a Bayesian projection from 2020 to 2030

Corrigendum: Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson's disease